DRIO · DarioHealth Corp.

DarioHealth Corp. has established a flexible capital-raising mechanism through an at-the-market equity offering program, allowing it to opportunistically sell common stock in the open market as needed. The agreement with A.G.P./Alliance Global Partners provides the company with access to up to $20 million in equity capital without the pressure of a traditional underwritten offering, as the company retains discretion over timing and amounts sold. The disclosed use of proceeds indicates a strategic focus on funding growth initiatives, including commercial expansion, product development, and potential mergers and acquisitions, while also addressing existing financial obligations through repayment of debt under its credit facility with Callodine Commercial Finance, LLC. The cost structure includes both fixed commission-based compensation and reimbursement for the agent's expenses, which is typical for such arrangements. The offering's reliance on an already-effective shelf registration statement provides regulatory efficiency, enabling the company to access capital markets quickly when market conditions are favorable.